See the DrugPatentWatch profile for cosentyx

There is currently no scientific evidence to suggest that the efficacy of vaccines is affected by the use of Cosentyx (secukinumab) [1]. Cosentyx is a medication used to treat various conditions such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [2]. It is a type of drug called a monoclonal antibody, which works by targeting and blocking a specific protein in the body called interleukin-17A [3].

It is important to note that while Cosentyx may affect the immune system, it does not necessarily mean that it will impact the effectiveness of vaccines. However, it is always recommended to consult with a healthcare provider before receiving any vaccinations while on medication [4]. They will be able to provide the most accurate and up-to-date information based on the individual's specific medical history and current treatment plan.

In summary, based on the available information, there is no evidence to suggest that vaccine efficacy is affected by using Cosentyx. However, it is always best to consult with a healthcare provider before receiving any vaccinations while on medication.

Sources:

1. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397053/>
2. <https://www.cosentyx.com/about-cosentyx>
3. <https://www.drugs.com/cosentyx.html>
4. <https://www.cdc.gov/vaccines/covid-19/info-by-product/cosentyx.html>
5. <https://www.drugpatentwatch.com/drugs/cosentyx>